ALIGN TECHNOLOGY INC Annual Report - A Deep Dive into Fiscal Year 2025

ALIGN TECHNOLOGY INC. (Nasdaq: ALGN), a global leader in medical devices for clear aligner therapy and digital intraoral scanning, delivered a strong performance in the fiscal year ending December 31, 2025. This report provides a comprehensive overview of the company's operations, financial health, and strategic direction over the past year.

Business Overview

ALIGN TECHNOLOGY, INC. (Nasdaq: ALGN) innovates the popular Invisalign clear aligner system and iTero intraoral scanners. These solutions are transforming orthodontic and restorative dentistry worldwide. The company designs, manufactures, and markets these products, which orthodontists and general practitioner dentists use to treat misaligned teeth and other dental conditions. As a mature and established public company, ALGN consistently provides timely and transparent financial reporting to the SEC, reflecting robust disclosure practices.

As of June 30, 2025, the company's publicly traded common stock held a market value of approximately $11.1 billion, underscoring its significant market presence. By February 20, 2026, approximately 71.3 million shares of common stock were outstanding.

Financial Performance Highlights for FY2025

ALIGN TECHNOLOGY achieved solid financial results in 2025, demonstrating continued growth and profitability:

• Total Revenue: The company generated net revenues of approximately $4.35 billion, a 9% increase from the previous year. Strong demand across both its Clear Aligner and Imaging Systems segments primarily drove this growth.
• Clear Aligner Segment: Revenue from Invisalign products reached $3.6 billion, an 8% increase year-over-year. The company shipped 2.5 million cases globally, reflecting continued adoption by both new and existing doctors.
• Imaging Systems & CAD/CAM Services Segment: This segment, featuring iTero scanners, generated approximately $750 million in revenue, marking a 14% increase from the prior year. This highlights the growing demand for digital dentistry solutions.
• Profitability: ALGN achieved a net income of approximately $780 million, resulting in diluted earnings per share (EPS) of $10.94. This performance reflects effective cost management and scaling efficiencies.

Management Discussion (MD&A Highlights)

ALIGN TECHNOLOGY further solidified its leadership in digital dentistry through several key initiatives, which contributed to its financial results and strategic positioning:

• Product Innovation: The company launched new Invisalign features, including enhanced AI-powered treatment planning tools and a next-generation aligner material designed to improve comfort and efficacy. The iTero platform also introduced new software capabilities for advanced restorative workflows, driving adoption and expanding its clinical utility.
• Market Expansion: ALGN expanded its presence in emerging markets, particularly across Asia-Pacific and Latin America, increasing its doctor base and patient reach. Strategic partnerships with dental service organizations (DSOs) also fostered broader adoption and market penetration.
• Research & Development: The company invested approximately $350 million in research and development. This investment focused on artificial intelligence, material science, and digital integration to maintain its competitive edge and drive future product pipelines.
• Operational Efficiency: Management focused on optimizing manufacturing processes and supply chain logistics to support increased demand and improve gross margins.
• Sustainability Initiatives: ALGN advanced its environmental, social, and governance (ESG) commitments. Initiatives included reducing its carbon footprint and enhancing supply chain sustainability, aligning with long-term stakeholder value creation.

Financial Health

The company demonstrated strong financial health and liquidity:

• Cash Flow: ALGN generated strong operating cash flow of $920 million, reinforcing its ability to fund operations and strategic initiatives without significant external financing.
• Cash and Equivalents: As of December 31, 2025, ALGN held a strong cash and cash equivalents balance of approximately $1.2 billion.
• Debt Profile: The company managed its debt effectively, maintaining a manageable debt profile. This strong balance sheet provides ample liquidity for future investments and operations, including potential share repurchases or strategic acquisitions.

Competitive Position

ALIGN TECHNOLOGY maintains a strong competitive position in the global dental market. This strength primarily stems from its proprietary technology, extensive intellectual property portfolio, and established brand recognition. The Invisalign system stands as a globally recognized brand synonymous with clear aligner therapy, benefiting from years of clinical research, product innovation, and a vast network of trained doctors. The iTero intraoral scanner further strengthens this position by integrating seamlessly into digital workflows, enhancing treatment planning and patient engagement.

While the clear aligner market faces intense competition from both traditional orthodontic solutions and other clear aligner providers, ALGN differentiates itself. Its comprehensive ecosystem, continuous R&D investment, and global operational scale set it apart. The company's ability to innovate and expand its product offerings, coupled with its strong relationships with dental professionals, are key factors in maintaining its market leadership.

Key Risk Factors

Investors should be aware of potential risks that could impact ALIGN TECHNOLOGY's business and financial results:

• Intense Competition: The clear aligner market is highly competitive, with both traditional orthodontic solutions and other clear aligner providers potentially impacting pricing and market share.
• Regulatory Changes: Potential regulatory changes in healthcare, particularly concerning medical devices and dental practices, could impose additional compliance costs or restrict market access.
• Economic Downturns: Global economic slowdowns or geopolitical uncertainties could impact consumer spending on elective treatments like orthodontics.
• Intellectual Property Challenges: Intellectual property challenges, including the expiration of key patents or successful challenges by competitors, could erode competitive advantages.
• Operational Disruptions: Supply chain disruptions, raw material price fluctuations, and manufacturing complexities could affect production and profitability.

The company actively monitors these factors and implements strategies to mitigate their potential impact.

Future Outlook

ALIGN TECHNOLOGY remains committed to its vision of transforming smiles and improving lives through innovative digital solutions. The company plans to continue significant investment in research and development to enhance its product portfolio, particularly in AI-powered treatment planning and advanced material science. Strategic initiatives include further expanding its global footprint, especially in underpenetrated international markets, and deepening its partnerships with dental professionals and organizations. The company aims to drive long-term growth by increasing the adoption of its Invisalign system and iTero scanners, solidifying its position as a leader in the digital dentistry industry. The company's strategy focuses on sustained innovation and market expansion.